64578-0145 NDC - LIPO-CHORD (ACETICUM AC, ACETYLSAL AC, ADRENOCORTICOTROPHIN, ALUMINA, ARSENICUM ALB, BORAGO, CEANOTHUS, CHELIDONIUM MAJ, CHIONANTHUS, CHLORAMPHENICOLUM, CHLORPROMAZINUM, CHOLESTERINUM, CORTISONE ACETICUM, DAMIANA, FOLLICULINUM, FUMARICUM AC, KALI IOD, LYCOPODIUM, NAT SULPHURICUM, NUX VOM, OLEUM MORRHUAE, PETROLEUM, PHENACETINUM, PHOSPHORICUM AC, PHOSPHORUS, PLUMB MET, SACCHARUM OFF, SILICEA, TARAXACUM, THYROIDINUM.)

Drug Information

Product NDC: 64578-0145

Proprietary Name: Lipo-Chord

Non Proprietary Name: Aceticum ac, Acetylsal ac, Adrenocorticotrophin, Alumina, Arsenicum alb, Borago, Ceanothus, Chelidonium maj, Chionanthus, Chloramphenicolum, Chlorpromazinum, Cholesterinum, Cortisone aceticum, Damiana, Folliculinum, Fumaricum ac, Kali iod, Lycopodium, Nat sulphuricum, Nux vom, Oleum morrhuae, Petroleum, Phenacetinum, Phosphoricum ac, Phosphorus, Plumb met, Saccharum off, Silicea, Taraxacum, Thyroidinum.

Active Ingredient(s):
  • 18 [hp_X]/59.1mL ACETIC ACID;
  • 18 [hp_X]/59.1mL ALUMINUM OXIDE;
  • 30 [hp_X]/59.1mL ARSENIC TRIOXIDE;
  • 18 [hp_X]/59.1mL ASPIRIN;
  • 6 [hp_X]/59.1mL BORAGE;
  • 6 [hp_X]/59.1mL CEANOTHUS AMERICANUS LEAF;
  • 12 [hp_X]/59.1mL CHELIDONIUM MAJUS;
  • 6 [hp_X]/59.1mL CHIONANTHUS VIRGINICUS BARK;
  • 18 [hp_X]/59.1mL CHLORAMPHENICOL;
  • 18 [hp_X]/59.1mL CHLORPROMAZINE;
  • 12 [hp_X]/59.1mL CHOLESTEROL;
  • 12 [hp_X]/59.1mL COD LIVER OIL;
  • 18 [hp_X]/59.1mL CORTICOTROPIN HUMAN;
  • 18 [hp_X]/59.1mL CORTISONE ACETATE;
  • 18 [hp_X]/59.1mL ESTRONE;
  • 30 [hp_X]/59.1mL FUMARIC ACID;
  • 18 [hp_X]/59.1mL KEROSENE;
  • 30 [hp_X]/59.1mL LEAD;
  • 30 [hp_X]/59.1mL LYCOPODIUM CLAVATUM SPORE;
  • 18 [hp_X]/59.1mL PHENACETIN;
  • 30 [hp_X]/59.1mL PHOSPHORIC ACID;
  • 30 [hp_X]/59.1mL PHOSPHORUS;
  • 30 [hp_X]/59.1mL POTASSIUM IODIDE;
  • 30 [hp_X]/59.1mL SILICON DIOXIDE;
  • 30 [hp_X]/59.1mL SODIUM SULFATE;
  • 30 [hp_X]/59.1mL STRYCHNOS NUX-VOMICA SEED;
  • 30 [hp_X]/59.1mL SUCROSE;
  • 4 [hp_X]/59.1mL TARAXACUM OFFICINALE;
  • 9 [hp_X]/59.1mL THYROID, UNSPECIFIED;
  • 12 [hp_X]/59.1mL TURNERA DIFFUSA LEAFY TWIG


Administration Route(s): ORAL

Dosage Form(s): LIQUID

Pharmacy Class(es):
  • Allergens [CS];
  • Amphenicol-class Antibacterial [EPC];
  • Amphenicols [EXT];
  • Anti-Inflammatory Agents;
  • Non-Steroidal [CS];
  • Cell-mediated Immunity [PE];
  • Corticosteroid Hormone Receptor Agonists [MoA];
  • Corticosteroid [EPC];
  • Cyclooxygenase Inhibitors [MoA];
  • Decreased Platelet Aggregation [PE];
  • Decreased Prostaglandin Production [PE];
  • Increased Histamine Release [PE];
  • Increased IgG Production [PE];
  • Non-Standardized Plant Allergenic Extract [EPC];
  • Nonsteroidal Anti-inflammatory Drug [EPC];
  • Phenothiazine [EPC];
  • Phenothiazines [CS];
  • Plant Proteins [CS];
  • Platelet Aggregation Inhibitor [EPC];
  • Seed Storage Proteins [CS]

Labeler Information

Labeler Name: Energetix Corporation
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:8/18/2017

Package Information

No. Package Code Package Description Billing Unit
164578-0145-159.1 mL in 1 BOTTLE, DROPPER (64578-0145-1)

NDC Record

Field Name Field Value Definition
PRODUCT NDC64578-0145The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMELipo-ChordThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEAceticum ac, Acetylsal ac, Adrenocorticotrophin, Alumina, Arsenicum alb, Borago, Ceanothus, Chelidonium maj, Chionanthus, Chloramphenicolum, Chlorpromazinum, Cholesterinum, Cortisone aceticum, Damiana, Folliculinum, Fumaricum ac, Kali iod, Lycopodium, Nat sulphuricum, Nux vom, Oleum morrhuae, Petroleum, Phenacetinum, Phosphoricum ac, Phosphorus, Plumb met, Saccharum off, Silicea, Taraxacum, Thyroidinum.The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMELIQUIDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE8/18/2017This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEEnergetix CorporationName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEACETIC ACID; ALUMINUM OXIDE; ARSENIC TRIOXIDE; ASPIRIN; BORAGE; CEANOTHUS AMERICANUS LEAF; CHELIDONIUM MAJUS; CHIONANTHUS VIRGINICUS BARK; CHLORAMPHENICOL; CHLORPROMAZINE; CHOLESTEROL; COD LIVER OIL; CORTICOTROPIN HUMAN; CORTISONE ACETATE; ESTRONE; FUMARIC ACID; KEROSENE; LEAD; LYCOPODIUM CLAVATUM SPORE; PHENACETIN; PHOSPHORIC ACID; PHOSPHORUS; POTASSIUM IODIDE; SILICON DIOXIDE; SODIUM SULFATE; STRYCHNOS NUX-VOMICA SEED; SUCROSE; TARAXACUM OFFICINALE; THYROID, UNSPECIFIED; TURNERA DIFFUSA LEAFY TWIGAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH18; 18; 30; 18; 6; 6; 12; 6; 18; 18; 12; 12; 18; 18; 18; 30; 18; 30; 30; 18; 30; 30; 30; 30; 30; 30; 30; 4; 9; 12 
ACTIVE INGRED UNIT[hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL 
PHARM CLASSESAllergens [CS], Amphenicol-class Antibacterial [EPC], Amphenicols [EXT], Anti-Inflammatory Agents, Non-Steroidal [CS], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Phenothiazine [EPC], Phenothiazines [CS], Plant Proteins [CS], Platelet Aggregation Inhibitor [EPC], Seed Storage Proteins [CS] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023